` COX (Nicox SA) vs DAX Index Comparison - Alpha Spread

COX
vs
D
DAX Index

Over the past 12 months, COX has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +13% growth.

Stocks Performance
COX vs DAX Index

Loading
COX
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
COX vs DAX Index

Loading
COX
DAX Index
Difference
www.alphaspread.com

Performance By Year
COX vs DAX Index

Loading
COX
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Nicox SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Nicox SA
Glance View

Market Cap
28.9m EUR
Industry
Biotechnology

Nicox SA is an ophthalmology company. The company is headquartered in Valbonne, Paca. The company is engaged in the field of the research, development and future commercialization of investigational drugs for ophthalmological diseases. The Company’s aim is to build a portfolio of therapeutic products addressing the needs of eye care practitioners and patients. Nicox SA offers its customers the Xailin range of ocular lubricants and AdenoPlus, a diagnostic test that aids in the differential diagnosis of acute conjunctivitis. The firm has also products in the pipeline, such as VESNEO (a drug-candidate for treating glaucoma) and AC-170 (for allergic conjunctivis). The company has a direct commercial presence in Germany, France, the United Kingdom, Italy and Spain, as well as partnerships with local distributors in a number of key international markets.

COX Intrinsic Value
Not Available
Back to Top